Esansiyel hipertansiyonlu hastalarda gözdibi muayene bulguları ve sol ventrikül hipertrofisi

Amaç: Esansiyel hipertansiyonlu hastalarda iki önemli komplikasyon olan hipertansif retinopâti (HR) ve sol ventrikül hipertrofisinin (SVH) prevalansmı incelemek ve aralarındaki ilişkiyi araştırmak amaçlandı. Yöntem: 35'i kadın, 25'i erkek, toplam 60 esansiyel hipertansiyonlu hasta çalışmaya alındı. Her hastada direkt oftalmaskopi ile HR; ekokardiyografi (EKO) ve elektrokardiyografi (EKG) ile SVH' nin varlığı araştırıldı. Hipertansiyonun derecesi ile bu bulgular arasındaki ilişki incelendi. Bulgular: Hastaların % 43.3'ünde EKO ile, % 16.6' smda EKG ile SVH, % 57.7'sinde hipertansif retinopâti (HR) tespit edildi. Hipertansiyonun derecesi ile HR ve EKO ile saptanan SVH prevalansı arasında ilişki saptandı. Ayrıca HRInin derecesi ile SVH prevalansı arasında anlamlı ilişki bulundu. Sonuç: Fundoskopik muayene esansiyel hipertansiyonda vasküler hasarın derecesinin saptanmasında tercih edilmesi gereken basit ve önemli bir yöntemdir.

Fundoscopic findings and left ventricular hypertrophy in patients with essential hypertension

Purpose: The aim of the study was to determine the prevalence and correlation of hypertensive retinopathy (HR) and left ventricular hypertrophy (LVH) in patients with essential hypertension. Method: Sixty patient with essential hypertension (35 female, 25 male) were enrolled in the study. Ophthalmologic examination, echocardiography (ECO) and electrocardiography (EGG) were performed to determine HR and LVH in all patients. The relationship among the grade of hypertension, HR and LVH were investigated. Findings: LVH was found in 43.3% with ECO and in 16.6 with EGG,. HR was found in 57.7% of all patients. There was a significant relationship between the prevalence of HR and the grade of HT. A'close relationship between the prevalence of LVH and the grade of hypertension was found. There was a significant relationship between the grade of HR and the prevalence of LVH. Conclusion: Ophtalmoscopic examination is a simple and important method for determining the grade of vascular damage in essential hypertension.

___

  • Williams GH. Hypertensive vascüuar disease. In: Wilson JD, Braunwald E, Isselbacher KJ, Fauci A.S, Hauser S.L, Kasper DL, editors. Harrison’s principles of internal medicine, 14 th edition. UBA: McGraw-Hill Corp; 1998. p.1384-6. Başerer T. Türkiye Klinikleri Oftalmaloji Derg 1995;4:365-8. Levy D, Garrison RJ, Savage DD. Prognostic implications of echocardiographically determined left ventricular mass in the Framingam Heart Study. N Eng J Med 1990; 322:1561-6. Waeber B, Brunner HR. Antihypertensive agents: Mechanism of drug action. In: Braunwald E, Hollenberg NK, editors. Atlas of heart diseases. Vol. 1. Singapore: Current Medicine; 1995. p:7.1-7.13. Mayet J, Chapman N, Shahi M. The effects on cardiac arrhytmias of antihypertensive therapy causing regression of left ventricular hypertrophy. Am J Hypertens 1997;10:611-8. National Heart, Lung and Blood İnstitute. The fifth report of the Joint National Commite on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1993;153:154-83. Devereux RB, Koren MJ, de Simone G, Okin PM, Kligfield P: Methods for detection of left ventricular hypertrophy: Application to hypertensive heart disease. Eur Heart J 1993;14(Suppl):8-15. Palatini P, Penzo M, Bongiovi S, Canali C, Pessina AC: Role of opthalmoscopy in arterial hypertension: A problem revisited, Cardiologia 1991;36:713-22. Melina D, Colivicchi F, Melina G: Target organ status and cardiovascular risk in borderline hypertension. Acta Cardiol 1992;47:481-5. Cerasola G, Cottone S, Mule G, Nardi E, Mangano MI, Andronico G et al. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens 1996;14:915-20.